No Data
No Data
Express News | Biostem Receives Institutional Review Board (Irb) Approval to Advance Clinical Study Evaluating the Value of Vendaje® Compared to the Standard of Care for Non-Healing Diabetic Foot Ulcers
Earnings Call Summary | BIOSTEM TECHNOLOGIES INC(BSEM.US) Q2 2024 Earnings Conference
BioStem Technologies GAAP EPS of $0.39 Beats by $0.27, Revenue of $74.5M Beats by $30.5M
Express News | Biostem Technologies, Inc. Q2 Revenue USD 74.5 Million
Express News | Biostem Technologies, Inc. Q2 Net Income USD 6.3 Million
Express News | Biostem Technologies, Inc. Q2 EPS USD 0.3
No Data